USHSTAT

USPTO USPTO 2009 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark USHSTAT was filed as Word mark on 06/24/2009 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/23/2011. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: June 14, 2018

Trademark form Word mark
File reference 77767342
Register number 4014320
Application date June 24, 2009
Publication date January 18, 2011
Entry date August 23, 2011

Trademark owner

Medawar Centre, Robert Robinson Avenue
OX44GA Oxford
GB

Trademark representatives

goods and services

1 Enzymes for scientific and research purposes; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science
5 Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations
10 Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes
42 Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products

ID: 1377767342